The young company’s eighth licensing deal brings in two RAS-targeting projects from Joyo.
ApexOnco Front Page
Recent articles
16 May 2024
The conference’s abstract drop features ASC4First in its plenary session.
15 May 2024
An early study of the group’s anti-CD47 project SL-172154 has seen waning efficacy, a heart attack and a death.
15 May 2024
Plenty of questions remain about the latest palazestrant data drop as investors hope for a Novartis buyout.
15 May 2024
The company scraps its lead project and clears out its C-suite, but there was already a precedent.
14 May 2024
The sale of remaining rights to Allogene ends acrimony between the two companies.
14 May 2024
ASCO is fast approaching, but in the meantime Olema will have an important readout.
14 May 2024
The company dribbles out more data on IMA203, and the numbers head in the right direction.
Recent Quick take
- 17 May 2024
- 17 May 2024
- 13 May 2024
- 10 May 2024
- 10 May 2024
- 8 May 2024
- 8 May 2024